Sitori 90mg Tablet

Product Overview

About Sitori

Sitori is a medication containing the active ingredient Etoricoxib, classified as COX-2 selective NSAID medication. Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to….

Key Benefits & Uses

• Used for: Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck
• Used for: It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to.
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Etoricoxib, the active ingredient in Sitori, belongs to the COX-2 selective NSAID medication class. Its clinical use follows the authorised labelling for Etoricoxib-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Sitori. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Sitori for extended periods without medical advice.